Article Menu
Need Help?
No Article Versions Notes Found
Cite
Saito, M.; Senjo, H.; Kanaya, M.; Izumiyama, K.; Mori, A.; Tanaka, M.; Morioka, M.; Ieko, M. Acquired Hemophilia A Developing Cerebral Infarction 36 Days after the Frequent Administration of Bypass Hemostatic Agents. Hematol. Rep. 2018, 10, 7453. https://doi.org/10.4081/hr.2018.7453
Saito M, Senjo H, Kanaya M, Izumiyama K, Mori A, Tanaka M, Morioka M, Ieko M. Acquired Hemophilia A Developing Cerebral Infarction 36 Days after the Frequent Administration of Bypass Hemostatic Agents. Hematology Reports. 2018; 10(3):7453. https://doi.org/10.4081/hr.2018.7453
Chicago/Turabian StyleSaito, Makoto, Hajime Senjo, Minoru Kanaya, Koh Izumiyama, Akio Mori, Masanori Tanaka, Masanobu Morioka, and Masahiro Ieko. 2018. "Acquired Hemophilia A Developing Cerebral Infarction 36 Days after the Frequent Administration of Bypass Hemostatic Agents" Hematology Reports 10, no. 3: 7453. https://doi.org/10.4081/hr.2018.7453
APA StyleSaito, M., Senjo, H., Kanaya, M., Izumiyama, K., Mori, A., Tanaka, M., Morioka, M., & Ieko, M. (2018). Acquired Hemophilia A Developing Cerebral Infarction 36 Days after the Frequent Administration of Bypass Hemostatic Agents. Hematology Reports, 10(3), 7453. https://doi.org/10.4081/hr.2018.7453
